Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 2,697,267 | 2,697,267 | 0 | $202.54M | $204.61M | 22.46% | +$2.08M |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,473,913 | 10,473,913 | 0 | $247.71M | $201.20M | 22.09% | -$46.50M |
| Disc Medicine, Inc.(IRON) | 1,317,213 | 1,795,735 | +478,522 | $82.01M | $80.93M | 8.89% | -$1.08M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,992,028 | 3,013,423 | +21,395 | $89.76M | $77.99M | 8.56% | -$11.77M |
| Pharvaris N V COM | 3,303,381 | 3,303,381 | 0 | $76.34M | $62.10M | 6.82% | -$14.24M |
| Savara Inc.(SVRA) | 14,565,457 | 14,565,457 | 0 | $72.54M | $58.70M | 6.44% | -$13.84M |
| Annexon, Inc.(ANNX) | 8,703,268 | 8,449,208 | -254,060 | $62.40M | $41.40M | 4.55% | -$21.00M |
| Kyverna Therapeutics, Inc.(KYTX) | 3,163,868 | 3,368,370 | +204,502 | $78.59M | $25.26M | 2.77% | -$53.33M |
| Tango Therapeutics, Inc.(TNGX) | 2,892,663 | 2,892,663 | 0 | $22.97M | $24.82M | 2.72% | +$1.85M |
| Solid Biosciences Inc | 4,034,582 | 4,034,582 | 0 | $53.74M | $22.88M | 2.51% | -$30.86M |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $38.81M | $17.41M | 1.91% | -$21.40M |
| Syros Pharmaceuticals Inc | 2,749,808 | 2,749,808 | 0 | $14.71M | $14.19M | 1.56% | -$522.5K |
| Century Therapeutics, Inc.(IPSC) | 0 | 5,410,361 | +5,410,361 | $0 | $13.80M | 1.51% | +$13.80M |
| Cabaletta Bio, Inc.(CABA) | 1,617,364 | 1,649,964 | +32,600 | $27.59M | $12.34M | 1.35% | -$15.25M |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 16,915,784 | 0 | $23.51M | $9.81M | 1.08% | -$13.70M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 2,011,687 | 1,030,703 | -980,984 | $19.94M | $9.59M | 1.05% | -$10.35M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $10.04M | $8.23M | 0.90% | -$1.81M |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $8.18M | $5.57M | 0.61% | -$2.61M |
| C4 Therapeutics, Inc.(CCCC) | 1,142,210 | 1,111,910 | -30,300 | $9.33M | $5.14M | 0.56% | -$4.19M |
| Nautilus Biotechnology, Inc.(NAUT) | 2,000,000 | 2,000,000 | 0 | $5.88M | $4.68M | 0.51% | -$1.20M |
| Xilio Therapeutics, Inc.(XLO) | 2,805,413 | 3,785,450 | +980,037 | $3.03M | $3.59M | 0.39% | +$556.9K |
| Marinus Pharmaceuticals Inc | 1,393,380 | 2,267,680 | +874,300 | $12.60M | $2.65M | 0.29% | -$9.94M |
| Invivyd, Inc.(IVVD) | 1,799,595 | 1,799,595 | 0 | $7.99M | $1.98M | 0.22% | -$6.01M |
| Aclaris Therapeutics, Inc.(ACRS) | 3,000,000 | 1,000,000 | -2,000,000 | $3.72M | $1.10M | 0.12% | -$2.62M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $1.10M | $872.0K | 0.10% | -$232.0K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 196,995 | 0 | -196,995 | $52.61M | $0 | — | -$52.61M |
| Nurix Therapeutics, Inc.(NRIX) | 1,132,397 | 0 | -1,132,397 | $16.65M | $0 | — | -$16.65M |